Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.374NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.63 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.377NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.298NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.76NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.384NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.494NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.167NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.165NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.554NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.243.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.450NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.130NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.268NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.344NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.103NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.119NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.276NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.111NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.336NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.400.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.548NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.24.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.492NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.540NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAANWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used